03:57 AM EDT, 08/08/2025 (MT Newswires) -- Cytokinetics ( CYTK ) reported a Q2 loss Thursday of $1.12 per diluted share, narrower than a loss of $1.31 a year earlier.
Analysts polled by FactSet expected a loss of $1.43.
Revenue for the quarter ended June 30 was $66.8 million, compared with $249,000 a year earlier.
zpostcode
Recruit
weather
mreligion
Yellowpages
sport
constellation
shopping
name
game
directory
literature
Word
tour
furnish
Lottery
tftnews
lyrics
News
digital
car
dir
Edu
Finance
